Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement
Physician's Weekly
JULY 1, 2025
Several authors disclosed ties to relevant organizations, including Eli Lilly, the manufacturer of tirzepatide. Abstract/Full Text (subscription or payment may be required) Copyright © 2025 HealthDay. All rights reserved.
Let's personalize your content